Prezcobix

Active Ingredient(s): Darunavir + Cobicistat
FDA Approved: * January 29, 2015
Pharm Company: * JANSSEN PRODS
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Prezcobix Overview

Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.[1] It is generally recommended for use with other antiretrovirals.[1] It is often used with low doses of ritonavir or cobicistat to increase darunavir levels.[1] It may be used for prevention after a needlestick injury or other potential exposure.[1] It is taken by mouth once to twice a day. ...

Read more Prezcobix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Darunavir

Recent Prezcobix Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Darunavir + Cobicistat
  • Tablet: 150mg + 800mg, 800mg + 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Prezcobix: (4 results)

Sorted by National Drug Code
  • 50090-1723 Prezcobix Oral Tablet, Film Coated by A-s Medication Solutions
  • 54569-6594 Prezcobix Oral Tablet, Film Coated by A-s Medication Solutions
  • 59676-575 Prezcobix Oral Tablet, Film Coated by Janssen Products Lp
  • 70518-0714 Prezcobix Oral Tablet, Film Coated by Remedyrepack Inc.

Drugs with one or more similar ingredients: (12 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA